Mitotech S.A. is a Luxembourg-based single-molecule biotechnology company with a portfolio of novel drugs for the treatment of age-related disorders undergoing early, middle and late stages of drug development. Our drug portfolio consists of an ophthalmic drug (Visomitin™) and a systemic drug (Plastomitin™) that both have our lead compound SkQ1 – a highly efficient mitochondria-targeted antioxidant – as their active in...
Mitotech S.A. is a Luxembourg-based single-molecule biotechnology company with a portfolio of novel drugs for the treatment of age-related disorders undergoing early, middle and late stages of drug development. Our drug portfolio consists of an ophthalmic drug (Visomitin™) and a systemic drug (Plastomitin™) that both have our lead compound SkQ1 – a highly efficient mitochondria-targeted antioxidant – as their active ingredient.
Our core team is a unique fusion of cross-disciplinary scientific experts, seasoned clinical drug development professionals and experienced business managers.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.